The integration into Rightway's modern PBM combines the transparent pricing of Cost Plus Drugs with Rightway's signature member experience, granting members direct access to the pharmacy.
Mark Cuban's drug company, Cost Plus Drugs, has added healthcare company Rightway to its network. This marks the first time a Pharmacy Benefit Manager (PBM) has added the pharmacy to its network.
This relationship grants members of Rightway's PBM direct access to all medications available through Cost Plus Drugs, according to a news release.
Rising pharmacy costs are one of the fastest-growing components employers are seeing within their companies. PBMs are leaving employers and patients with few options to curb rising costs.
Cost Plus Drugs has built a parallel supply chain, sidestepping the limitations of the current PBM landscape altogether and unlocking an unprecedented level of transparency, flexibility and availability for consumers to fill their generic prescriptions. The prices at Cost Plus Drugs are at cost with a 15% markup. Prescriptions are delivered by mail, further lowering the cost per pill as mail-order medications are dispensed in greater quantities.
The integration into Rightway's modern PBM combines the transparent pricing of Cost Plus Drugs with Rightway's signature member experience, granting members direct access to the pharmacy from within the Rightway mobile app.
"Rightway's relationship with Cost Plus Drugs demonstrates our commitment to making it as easy as possible for members to get the absolute lowest price available for their prescriptions," said Scott Musial, Chief Pharmacy Officer of Rightway, in the release. "Cost Plus Drugs offers some of the lowest prices in the market. It enables Rightway to step away from the traditional supply chain, offering our members greater choice, lowering their spending, and giving them back time they'd spend at the pharmacy. Entrants like Cost Plus Drugs are welcome warriors in the battle against sky-high drug prices."
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
July 25th 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More